CapsoVision, Inc. Common Stock Cash Flow Conversion Efficiency

Latest as of June 2026: -0.638x

CapsoVision, Inc. Common Stock cash flow conversion efficiency. Based on the latest financial reports, CapsoVision, Inc. Common Stock (CV) has a cash flow conversion efficiency ratio of -0.638x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-8.40 Million) by net assets ($13.17 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of CapsoVision, Inc. Common Stock (2023–2025)

Cash flow conversion efficiency of CapsoVision, Inc. Common Stock from 2023 to 2025. This chart illustrates how CapsoVision, Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for CapsoVision, Inc. Common Stock for real-time trading data and today's change.

CapsoVision, Inc. Common Stock Cash Flow Conversion Ratio Explained

CapsoVision, Inc. Common Stock cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

CapsoVision, Inc. Common Stock Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of CapsoVision, Inc. Common Stock ranked by their cash flow conversion efficiency. Also see CapsoVision, Inc. Common Stock (CV) total market value for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Lanpec Technologies Ltd
SHG:601798
0.027x
Bank Bukopin Tbk
JK:BBKP
-0.331x
Jing Jin Electric Technologies Co Ltd
SHG:688280
0.340x
Dongguan Chitwing Technology Co Ltd
SHE:002855
0.242x
medmix AG
SW:MEDX
0.086x
Third Point Investors Limited
LSE:TPOU
-0.004x
Atria Oyj A
HE:ATRAV
-0.010x
Annil Co Ltd
SHE:002875
-0.002x

Annual Cash Flow Conversion Efficiency for CapsoVision, Inc. Common Stock (2023–2025)

The table below shows the annual cash flow conversion efficiency of CapsoVision, Inc. Common Stock from 2023 to 2025. Review CapsoVision, Inc. Common Stock leverage flexibility ratio to assess the company's free cash flow relative to its total liabilities.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $13.26 Million $-22.86 Million -1.724x -1211.50%
2024-12-31 $-129.51 Million $-20.09 Million 0.155x +57.75%
2023-12-31 $-109.84 Million $-10.80 Million 0.098x --

About CapsoVision, Inc. Common Stock

NASDAQ:CV USA Medical Devices
Market Cap
$356.51 Million
Market Cap Rank
#13725 Global
#3321 in USA
Share Price
$6.70
Change (1 day)
-0.45%
52-Week Range
$4.64 - $14.42
All Time High
$14.42
About

CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement … Read more